A revolutionary new treatment for rheumatoid arthritis. #StartActivating #SetPointSystem #SetPointTherapy Individual outcomes vary. Safety info: https://nitter.cf/t.co/BhikdgoQHO
Valencia, CA
Joined October 2013
- Tweets161
- Following42
- Followers624
- Likes35
Pinned Tweet
It’s official! #SetPointSystem is now FDA approved for the treatment of rheumatoid arthritis (RA) in adults who are not adequately managed by, or who cannot tolerate, existing advanced RA therapies.
See the release: setpointmedical.com/setpoint… #Rheumatology #RheumTwitter #MedTwitter
New 24-month RESET-RA data at #ACR26 show sustained clinical responses and favorable long-term safety with the SetPoint System for rheumatoid arthritis.
Learn More: setpointmedical.com/setpoint…
Safety Info: spm.care/ISI
THIS WEEKEND! Dr. John Tesser presents RESET-RA 2-year efficacy and safety results 11/9 at 2:30 p.m. ET at #ACR26.
Add the presentation to your calendar (spm.care/ACR26) and don’t forget to stop by Booth #2013 to meet our team!
Safety: spm.care/ISI
@ACRheum
New Mexico is now activated 👏
Neurosurgeon James Botros, M.D. and the @UNMHospital team join the growing list of centers expanding access to #SetPointTherapy.
Read: setpointmedical.com/setpoint…
Individual outcomes vary. See important safety information: spm.care/ISI
Partnership is key to bringing innovation to patients. Hear John D’Angelo discuss @NorthwellHealth’s role in advancing care for people with #RheumatoidArthritis and the #SetPointSystem podcast.show/beckershealthca…
Safety: spm.care/ISI #NeuroimmuneModulation #StartActivating
Listen Here: podcasts.apple.com/us/podcas…
In this episode, John D'Angelo, MD, FACEP, President and CEO of @NorthwellHealth, discusses a fundamentally different approach to treating rheumatoid arthritis (RA): bioelectronic medicine, which uses the body’s own nervous system to help regulate the inflammation that drives the disease. Delivered by a small implanted medical device that stimulates the vagus nerve, the FDA-approved therapy offers an alternative to costly medications that can also cause significant side effects or fail to provide adequate relief. #podcast #healthcare #leadership
We’re excited to announce that Beth Israel Deaconess Medical Center completed its first #SetPointSystem procedure in Boston, expanding access to a new treatment option for adults with rheumatoid arthritis in the New England area.
Read the release: setpointmedical.com/setpoint…
We’re pleased to welcome Dan Dearen to our Board of Directors. Dan brings nearly four decades of MedTech leadership and a track record of building and scaling high-growth companies, adding seasoned perspective as we continue to expand.
Read the release: setpointmedical.com/setpoint…
1
82
We’re grateful to @OHSUNews for being at the forefront of exploring new therapies including the #SetPointSystem for #RA, it's helping push the field forward and expand what’s possible for patients.
Read More: news.ohsu.edu/2026/10/01/ohs…
Safety Info: spm.care/ISI
80
We’re honored to be recognized on @FastCompany’s 2026 Next Big Things in Tech list as a groundbreaking technology with the potential to redefine treatment for patients with rheumatoid arthritis
Read the full release: setpointmedical.com/setpoint…
#FCTechAwards
1
70
NJ is now activated with the first #SetPointSystem procedures completed! @AtlantiCareNJ, @gni_neuro, and @AtlanticHealth together are expanding access to FDA-approved #NeuroimmuneModulation across NJ, DE & Eastern PA. Read More: setpointmedical.com/global-n…
78
Thank you, @CCRheumatology for a great weekend. Seeing #NeuroimmuneModulation presented as an RA treatment — and met with real enthusiasm — says a lot about where this field is headed. Learn more: healio.com/news/rheumatology…
#StartActivating #SetPointAdvantage #Rheumatology
1
126
The first patient in the Pacific Northwest has been treated with the #SetPointSystem for rheumatoid arthritis at @OHSUNews, bringing #SetPointTherapy to communities across Oregon.
Read more: setpointmedical.com/setpoint…
Individual outcomes vary. See ISI: spm.care/ISI
Join us and @USSONAR_Rh Monday, October 5th at 8:30 pm ET for a webinar with Dr. Jeffrey Curtis (UAB) to discuss vagus nerve-mediated neuroimmune modulation, a novel therapy treatment for rheumatoid arthritis.
Register today: spm.care/webinar
4
186
The first Minnesota patient has been treated with the #SetPointSystem for rheumatoid arthritis, bringing #SetPointTherapy to the Twin Cities, Rochester & surrounding communities.
Read more: setpointmedical.com/first-pa…
Individual outcomes vary. See ISI: spm.care/ISI
On @AmericaMedicine, Ken with @minnakohlermd shares his #SetPointTherapy story and tips for how he navigated new treatment options with his rheumatologist. A must-listen for people living with #RA👇
electracast.com/podcast/medi…
Individual outcomes vary. ISI: spm.care/ISI
(1/2) New on @HRheuminations: @LCalabreseDO and Dr. Chernoff explore the story behind vagus nerve’s anti-inflammatory pathways, the science of neuroimmune modulation, & the clinical journey leading to its use in rheumatoid arthritis.
Listen: spm.care/healio_107
#RA
🚨Special episode alert 🚨Rheuminations guest host @LCalabreseDO speaks with David Chernoff, MD @SetPointMed about vagal nerve stimulation and recent developments in immune mediated disease. Listen here 🎙️vist.ly/5cwhx
#Rheumatology #Podcast
(2/2) Indicated for use in the treatment of adults with moderately to severely active RA who have had an inadequate response, loss of response, or intolerance to one or more biological or targeted synthetic disease-modifying antirheumatic drugs. spm.care/ISI
40
We’re excited to announce that the first #SetPointSystem procedure in North Carolina was completed in collaboration with Arthritis & Osteoporosis Consultants of the Carolinas (AOCC).
Read the announcement: setpointmedical.com/arthriti…
1
2
112
A landmark @MedEconomics study projects the #SetPointSystem could save the U.S. health system per patient over a lifetime compared to standard-of-care, with costs potentially recouped within 16 months.
Read here: setpointmedical.com/publicat…
Safety info: spm.care/ISI
1
82
We're proud to announce we've enrolled the first patients in our investigational pilot study evaluating the #SetPointSystem for relapsing-remitting #multiplesclerosis (RRMS).
Safety & effectiveness have not been established for multiple sclerosis.
#MS
setpointmedical.com/setpoint…
115
We’re excited to announce our partnership with @lovellgov to expand access to the #SetPointSystem across federal healthcare systems.
Safety info: spm.care/ISI
#StartActivating #Rheumatology #RA #MedTwitter
Read more: setpointmedical.com/setpoint…
1
107